Keros Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $269.4M
Liabilities Breakdown FY2020
Total Liabilities: $7.7M
Asset Breakdown
Total Assets: $269.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $265.9M | 98.7% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $724.0K | 0.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $2.8M | 1.1% |
Liabilities Breakdown
Total Liabilities: $7.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.1M | 27.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $5.6M | 72.2% |